Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDICO SUPPORT A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.0% 5.8% 4.1% 6.7% 2.4% 2.0% 13.0% 13.0%   Credit score (0-100)   51 40 48 35 63 69 18 18   Credit rating   BBB BBB BBB BBB BBB A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   8,259 8,267 9,518 9,267 11,895 13,735 0.0 0.0   EBITDA   -592 -1,062 832 311 2,756 2,604 0.0 0.0   EBIT   -1,029 -1,552 344 -62.0 2,397 2,172 0.0 0.0   Pre-tax profit (PTP)   -1,062.3 -1,817.0 197.6 -408.7 2,062.4 1,973.6 0.0 0.0   Net earnings   -903.6 -1,608.0 260.0 -466.9 1,875.4 1,525.0 0.0 0.0   Pre-tax profit without non-rec. items   -1,062 -1,817 198 -409 2,062 1,974 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   1,244 1,039 946 1,001 850 1,288 0.0 0.0   Shareholders equity total   3,964 2,356 2,616 2,149 4,025 4,450 1,094 1,094   Interest-bearing liabilities   3,079 2,609 2,298 3,543 2,889 1,823 0.0 0.0   Balance sheet total (assets)   8,781 9,090 10,176 10,039 11,635 10,884 1,094 1,094   Net Debt   3,078 2,608 1,273 3,543 2,889 1,822 -1,094 -1,094     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   8,259 8,267 9,518 9,267 11,895 13,735 0.0 0.0   Gross profit growth   -12.0% 0.1% 15.1% -2.6% 28.4% 15.5% -100.0% 0.0%   Employees   13 14 13 13 13 15 0 0   Employee growth %   0.0% 7.7% -7.1% 0.0% 0.0% 15.4% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   8,781 9,090 10,176 10,039 11,635 10,884 1,094 1,094   Balance sheet change%   6.9% 3.5% 11.9% -1.3% 15.9% -6.5% -89.9% 0.0%   Added value   -592.1 -1,061.9 832.2 311.2 2,769.9 2,604.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -216 -319 -216 119 -480 118 -3,667 0   Net sales trend   -1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -12.5% -18.8% 3.6% -0.7% 20.1% 15.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -11.4% -16.7% 4.5% 0.4% 23.1% 20.0% 0.0% 0.0%   ROI %   -16.0% -21.2% 6.7% 0.7% 39.1% 32.4% 0.0% 0.0%   ROE %   -20.5% -50.9% 10.5% -19.6% 60.7% 36.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   45.1% 25.9% 25.4% 21.4% 34.6% 40.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -519.9% -245.7% 152.9% 1,138.6% 104.8% 70.0% 0.0% 0.0%   Gearing %   77.7% 110.7% 87.8% 164.8% 71.8% 41.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.8% 11.5% 9.7% 15.3% 13.7% 12.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.9 0.7 0.9 0.7 1.2 1.5 0.0 0.0   Current Ratio   1.0 0.9 1.0 0.9 1.3 1.6 0.0 0.0   Cash and cash equivalent   0.4 0.4 1,025.3 0.0 0.5 0.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -49.4 -521.2 140.5 -608.1 1,596.4 2,661.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -46 -76 64 24 213 174 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -46 -76 64 24 212 174 0 0   EBIT / employee   -79 -111 26 -5 184 145 0 0   Net earnings / employee   -70 -115 20 -36 144 102 0 0